A novel in vitro model to investigate behavior of articular chondrocytes in osteoarthritis

Journal of Rheumatology

Volumn 37, Issue 2, 2010, Pages 426-431

  Rankin, Kenneth S ^a   Lakey, Rachel L ^a   Gerrand, Craig H ^a   Sprowson, Andrew P ^a   McCaskie, Andrew W ^a   Birch, Mark A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Articular chondrocytes; Cartilage matrix; Metalloproteinase; Osteoarthritis

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; COLLAGEN TYPE 2; FLUORESCENT DYE; GLYCOSAMINOGLYCAN; INTERSTITIAL COLLAGENASE; OXYGEN; POLYMACON; PROTEOGLYCAN; TRANSCRIPTION FACTOR SOX9; VINCULIN;

ARTICLE; CARTILAGE CELL; CELL GROWTH; CELL STRUCTURE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MICROENVIRONMENT; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIMULATION; SURFACE PROPERTY; TRANSCRIPTION REGULATION; UPREGULATION;

ANALYSIS OF VARIANCE; ANOXIA; CARTILAGE, ARTICULAR; CELL CULTURE TECHNIQUES; CELL SHAPE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MATRIX METALLOPROTEINASE 1; OSTEOARTHRITIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR;

EID: 76649127709     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080080     Document Type: Article

References (18)

1. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol 2006;20:1003-25.
2. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000;43:1916-26.
3. Muir H. The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995;17:1039-48.
4. Van der Kraan PM, Van den Berg WB. Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing. Ageing Res Rev 2008;2:106-13.
5. Stewart MC, Saunders KM, Burton-Wurster N, MacLeod JN. Phenotypic stability of articular chondrocytes in vitro: the effects of culture models, bone morphogenetic protein 2 and serum supplementation. J Bone Miner Res 2000;15:166-74.
6. Zhao Q, Eberspaecher H, Lefebvre V, De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 1997;209:377-86.
7. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 2004;427 Suppl:S6-15.
8. Stokes DG, Liu G, Dharmavaram R, Hawkins D, Piera-Velazquez S, Jimenez SA. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific pheonotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J 2001;360:461-70.
9. Hardingham T, Tew S, Murdoch A. Tissue engineering: chondrocytes and cartilage. Arthritis Res 2002;4 Suppl 3:S63-8.
10. Tew SR, Clegg PD, Brew CJ, Redmond CM, Hardingham TE. SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis. Arthritis Res Ther 2007;9:R107.
11. Murphy CL, Polak JM. Control of human chondrocyte differentiation by reduced oxygen tension. J Cell Physiol 2004;199:451-9.
12. Zwingmann J, Mehlhorn AT, Sudkamp N, Stark B, Dauner M, Schmal H. Chondrogenic differentiation of human articular chondroctyes differs in biodegradable PGA/PLA scaffolds. Tissue Engineering 2007;13:2335-43.
13. Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998;41:1760-71.
14. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276-80.
15. Bush PG, Huntley JS, Brenkel IJ, Hall AC. The shape of things to come: chondrocytes and osteoarthritis. Clin Invest Med 2003;26:249-51.
16. Estrada LE, Dodge GR, Richardson DW, Farole A, Jimenez SA. Characterization of a biomaterial with cartilage-like properties expressing type X collagen generated in vitro using neonatal porcine articular and growth plate chondrocytes. Osteoarthritis Cartilage 2001;9:169-77.
17. Lafont JE, Talma S, Hopfgarten C, Murphy CL. Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways. J Biol Chem 2008;283:4778-86.
18. Yang KG, Saris DB, Geuze RE, van Rijen MH, van der Helm YJ, Verbout AJ, et al. Altered in vitro chondrogenic properties of chondrocytes harvested from unaffected cartilage in osteoarthritic joints. Osteoarthritis Cartilage 2006;14:561-70.